Risk adjustment in outcome assessment: the Charlson comorbidity index.
about
Regional variation in hospitalization for stroke among Asians/Pacific Islanders in the United States: a nationwide retrospective cohort study.Complication avoidance with pre-operative screening: insights from the Seattle spine teamComorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspectivePrognostic impact of standard laboratory values on outcome in patients with sudden sensorineural hearing lossEffect of advanced access scheduling on processes and intermediate outcomes of diabetes care and utilization.The predictability of claim-data-based comorbidity-adjusted models could be improved by using medication dataConsistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization dataFrontal Lobe Function and Risk of Hip Fracture in Patient With Alzheimer Disease: An Analysis of Linked DataThe outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from TaiwanEarly discontinuation and restart of insulin in the treatment of type 2 diabetes mellitusDoes comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort studyNurse forecasting in Europe (RN4CAST): Rationale, design and methodology.Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancerEnvironmental Exposures and the Risk of Central Venous Catheter Complications and Readmissions in Home Infusion Therapy PatientsA comparison of comorbidities obtained from hospital administrative data and medical charts in older patients with pneumoniaPerceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions.Comparison of artificial neural network and logistic regression models for predicting in-hospital mortality after primary liver cancer surgery.Hospitalized cardiovascular events in patients with diabetic macular edemaImproved comorbidity adjustment for predicting mortality in Medicare populations.Socioeconomic differences in waiting times for elective surgery: a population-based retrospective study.Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based studyThe effect of English language proficiency on length of stay and in-hospital mortality.A combined comorbidity score predicted mortality in elderly patients better than existing scores.Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.Relationship between duration of hospital-acquired acute kidney injury and mortality: a prospective observational study.The impact of comorbid depression on adherence to therapy for multiple sclerosis.Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetesMeasures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide.Health state information derived from secondary databases is affected by multiple sources of biasDiabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.Early interdisciplinary hospital intervention for elderly patients with hip fractures : functional outcome and mortality.Pancreaticoduodenectomy in Florida: do 20-year trends document the salutary benefits of centralization of care?Maximum Urine Flow Rate of Less than 15ml/Sec Increasing Risk of Urine Retention and Prostate Surgery among Patients with Alpha-1 Blockers: A 10-Year Follow Up Study.Associations between the patient-centered medical home and preventive care and healthcare quality for non-elderly adults with mental illness: A surveillance study analysisAre Multimorbidities Underestimated in Scoring Systems of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Like in SCORTEN?Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in TaiwanCHADS2 scores as a predictor of ischemic stroke after radical prostatectomy.Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilizationThe changing characteristics of atrial fibrillation patients treated with warfarin.
P2860
Q24815205-3BD5A814-7174-48CA-8A53-61876AF7F6D8Q26748734-76B1F554-C84D-4B12-96AA-A575FE5E8188Q26775957-1754D0ED-513D-441B-8480-315745E3AC0AQ30434745-9331B3F7-AADB-403D-8636-7F784FC67857Q30484030-E2E3D317-4E2C-46C6-A1C7-285E00545FC1Q30698080-165C6980-C0E7-4B48-931B-43B80DF805FBQ30925301-B83E0D1B-5872-49A6-895C-DD8C1A1AF076Q31021791-16408D3C-83ED-402A-8635-68A2D7D6D201Q33757573-0BBE016A-ED1B-41EA-B970-EEB8AC83CD14Q33785208-977D6C43-A6BA-4F92-B506-32913962E88CQ33870527-B7A11EE9-6CE8-4C3C-8BA7-CF8922FE1743Q33875882-37426B48-A0C4-48B5-98BF-D8B80EDCAB89Q33877542-501B652D-BA66-4B75-8059-FAF64BCBB8ADQ33885673-FE7F8432-BA2A-465D-A615-98758ECC2CA6Q33903546-4A471AE0-8D3F-46D7-AE25-2C33CC297F66Q34050227-51EEF981-0BB1-4FA1-A186-1E46604DF4D0Q34259742-CDAD7EAB-99D3-4B64-BD0B-F7B06246B238Q34286328-1C2DC9BB-012E-4BE0-88DE-731F8BA36DA0Q34335968-6CDAD95E-E5B4-4432-955D-833F7C39D490Q34386840-715C97C5-6F4B-4BD2-8A11-F531D20B5C62Q34716438-8180C3CB-3185-46E3-AAE1-8EAA52422D95Q34731718-080D1923-EAF5-42C5-9C39-9F88C8FE1633Q35000472-19B34D76-DE2A-4BE7-8B1A-92254B9C8CB1Q35091777-759733FD-576E-4824-BA0D-0EFF8DA38A3DQ35152650-1194EEBF-5D90-42BF-8452-63214576F928Q35391016-68210B82-ACF7-4070-8C37-1911F4D3A8BBQ35766301-439B41DA-1E27-47C2-AC1B-4396A9A2AAC1Q35860131-EECF3EC1-9B91-4B5F-9AD0-3D8321A8D20FQ35950467-E4FF7333-C9B0-4F79-A9BE-528627A7AF4CQ35972690-A676323B-6BCA-470A-94F7-040C8A536CE4Q36017224-3A68520D-FD32-4754-A716-2F4E28C552D3Q36019708-A011D7EF-D07D-4F08-84AD-7486CD5EDDE7Q36101355-D7C6E171-CC17-4DD0-8795-2894F388B37AQ36111991-6EEA0A55-5C06-4485-A0C7-1C1FFC0703A2Q36138175-550EA17C-82BD-4E42-8AB9-E9B4E3E8F66AQ36200626-AECAA164-7852-400B-A262-8A5513679AB2Q36325409-28B0772B-117C-4429-AB72-89BA537EF11BQ36451523-C3B3B762-B636-4C05-858C-5F176EFE1214Q36567472-7BD415F8-4567-4C59-B015-275BF5C1DC93Q36635772-A5A68E3D-A65A-46DF-963A-6408AC3914EE
P2860
Risk adjustment in outcome assessment: the Charlson comorbidity index.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Risk adjustment in outcome assessment: the Charlson comorbidity index.
@en
Risk adjustment in outcome assessment: the Charlson comorbidity index.
@nl
type
label
Risk adjustment in outcome assessment: the Charlson comorbidity index.
@en
Risk adjustment in outcome assessment: the Charlson comorbidity index.
@nl
prefLabel
Risk adjustment in outcome assessment: the Charlson comorbidity index.
@en
Risk adjustment in outcome assessment: the Charlson comorbidity index.
@nl
P2093
P1476
Risk adjustment in outcome assessment: the Charlson comorbidity index
@en
P2093
P304
P577
1993-11-01T00:00:00Z